Filing Flows › Xylem (XYL) › Q3 2026 › vs Q3 2025
Xylem (XYL) Q3 2026 vs Q3 2025 (year over year)
Xylem's revenue fell $67.0M (-3%) from $2.3B in Q3 2025 to $2.2B in Q3 2026. The biggest changes: Product −$60.0M (-3%); Service −$7.0M (-2%). Gross margin 41.2% against 38.9% (+2.3 pts).
Xylem, Q3 2026: revenue $2.2B (-3% year over year), operating margin 17.5%, net earnings $291M, operating cash flow $331M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 41.2% | 38.9% | +2.3 pts |
| Operating margin | 17.5% | 14.7% | +2.8 pts |
| Net margin | 13.2% | 10.0% | +3.2 pts |
| Free cash flow margin | 11.0% | 12.4% | -1.4 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Product | $1.8B | $1.9B | −$60.0M | -3% |
| Service | $394M | $401M | −$7.0M | -2% |
| Revenue | $2.2B | $2.3B | −$67.0M | -3% |
| Gross profit | $907M | $883M | $24.0M | +3% |
| Cost of revenue | $1.3B | $1.4B | −$91.0M | -7% |
| Operating profit | $385M | $334M | $51.0M | +15% |
| Operating expenses | $522M | $549M | −$27.0M | -5% |
| Pre-tax earnings | $365M | $297M | $68.0M | +23% |
| Other expense, net | $20.0M | $37.0M | −$17.0M | -46% |
| Research & development | $56.0M | $52.0M | $4.0M | +8% |
| SG&A | $458M | $474M | −$16.0M | -3% |
| Other operating costs | $8.0M | $23.0M | −$15.0M | -65% |
| Loss borne by minority interests | $3.0M | $1.0M | $2.0M | +200% |
| Net earnings | $291M | $227M | $64.0M | +28% |
| Income tax | $77.0M | $71.0M | $6.0M | +8% |
| Depreciation & amortization | $137M | $142M | −$5.0M | -4% |
| Share-based compensation | $14.0M | $12.0M | $2.0M | +17% |
| Working capital & other | $111M | $21.0M | $90.0M | +429% |
| Operating cash flow | $331M | $360M | −$29.0M | -8% |
| Free cash flow (OCF − capex) | $242M | $281M | −$39.0M | -14% |
| Capital expenditures | $89.0M | $79.0M | $10.0M | +13% |
Questions
How much did Xylem's revenue grow year over year in Q3 2026?
Xylem's revenue fell $67.0M (-3%) from $2.3B in Q3 2025 to $2.2B in Q3 2026.
What drove Xylem's revenue change in Q3 2026?
Product −$60.0M (-3%); Service −$7.0M (-2%).